1,773 results on '"Herr, Harry W."'
Search Results
2. Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy
3. Health-related Quality of Life for Patients Undergoing Radical Cystectomy: Results of a Large Prospective Cohort
4. Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinoma
5. Neoadjuvant Gemcitabine-Cisplatin Plus Radical Cystectomy-Pelvic Lymph Node Dissection for Muscle-invasive Bladder Cancer: A 12-year Experience
6. DEVELOPMENT OF A GENOMIC PREDICTION MODEL FOR UPPER TRACT UROTHELIAL CARCINOMA STAGE
7. Response to 2 Induction Courses of Bacillus Calmette-Guèrin Therapy Among Patients With High-Risk Non–Muscle-Invasive Bladder Cancer
8. Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype
9. Genomic Differences Between “Primary” and “Secondary” Muscle-invasive Bladder Cancer as a Basis for Disparate Outcomes to Cisplatin-based Neoadjuvant Chemotherapy
10. The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy
11. Comparison of Postradical Cystectomy Ileus Rates Using GIA-80 Versus GIA-60 Intestinal Stapler Device
12. Conservative Management Following Complete Clinical Response to Neoadjuvant Chemotherapy of Muscle Invasive Bladder Cancer: Contemporary Outcomes of a Multi-Institutional Cohort Study
13. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes
14. Intratumoral heterogeneity of ERBB2 amplification and HER2 expression in micropapillary urothelial carcinoma
15. Clinical Outcomes of Patients With T1 Nested Variant of Urothelial Carcinoma Compared to Pure Urothelial Carcinoma of the Bladder
16. Urothelial neoplasms in pediatric and young adult patients: A large single-center series
17. Penile cancer: Clinical Practice Guidelines in Oncology.
18. Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy
19. Health-related Quality of Life After Robotic-assisted vs Open Radical Cystectomy: Analysis of a Randomized Trial. Reply.
20. From Galen's Urine to Harvey's Blood
21. Goal-directed versus Standard Fluid Therapy to Decrease Ileus after Open Radical Cystectomy: A Prospective Randomized Controlled Trial
22. Bladder Tumors: Association with Upper Tract Neoplasms
23. Narrow Band Cystoscopy
24. Narrow Band Imaging for Urothelial Cancer
25. Reply by Authors
26. Cystoscopy and intravesical bacille Calmette–Guérin therapy in antibiotic-naïve patients with bladder cancer with asymptomatic bacteriuria: An update
27. Association of Biochemically Verified Post-Diagnosis Smoking and Nonmuscle-Invasive Bladder Cancer Recurrence Risk
28. Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma
29. An Interleukin-15 Superagonist with BCG — A Major Therapeutic Advancement or Just a Small Step in the Right Direction?
30. A Cost-effectiveness Analysis of Management of Low-risk Non–muscle-invasive Bladder Cancer Using Office-based Fulguration
31. The Risk of Urinary Tract Infection after Flexible Cystoscopy in Patients with Bladder Tumor Who Did Not Receive Prophylactic Antibiotics
32. Bladder Biopsy of Normal-Appearing Mucosa is Not Helpful in Patients with Unexplained Positive Cytology after Nonmuscle Invasive Bladder Cancer
33. Clinical Value of Transurethral Second Resection of Bladder Tumor: Systematic Review
34. Gender Disparities in Hematuria Evaluation and Bladder Cancer Diagnosis: A Population Based Analysis
35. Clinical Outcome of Patients with T1 Micropapillary Urothelial Carcinoma of the Bladder
36. Adherence to surveillance guidelines after radical cystectomy: A population-based analysis
37. The Effect of Restaging Transurethral Resection on Recurrence and Progression Rates in Patients with Nonmuscle Invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guérin
38. Risk Factors and Predictors of Severity Score and Complications of Pediatric Hemorrhagic Cystitis
39. Urethral Melanoma – Clinical, Pathological and Molecular Characteristics
40. NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022
41. Office-based Management of Nonmuscle Invasive Bladder Cancer
42. Intravesical Gemcitabine for High Risk, Nonmuscle Invasive Bladder Cancer after Bacillus Calmette-Guérin Treatment Failure
43. Upper Tract Imaging Surveillance is not Effective in Diagnosing Upper Tract Recurrence in Patients Followed for Nonmuscle Invasive Bladder Cancer
44. Management of Bladder Cancer After Renal Transplantation
45. Preoperative Accuracy of Diagnostic Evaluation of the Urachal Mass
46. Urinary Diversion Practice Patterns Among Certifying American Urologists
47. Idiographic quality of life assessment before radical cystectomy
48. Intravesical Bacillus Calmette-Guérin Outcomes in Patients With Bladder Cancer and Asymptomatic Bacteriuria
49. Renal Function and Oncologic Outcomes of Parenchymal Sparing Ureteral Resection Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
50. Comparative Outcomes of Pure Squamous Cell Carcinoma and Urothelial Carcinoma With Squamous Differentiation in Patients Treated With Radical Cystectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.